608 related articles for article (PubMed ID: 24006178)
1. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.
Kramann R; DiRocco DP; Humphreys BD
J Pathol; 2013 Nov; 231(3):273-89. PubMed ID: 24006178
[TBL] [Abstract][Full Text] [Related]
2. Pericytes in kidney fibrosis.
Ren S; Duffield JS
Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):471-80. PubMed ID: 23722183
[TBL] [Abstract][Full Text] [Related]
3. Host responses in tissue repair and fibrosis.
Duffield JS; Lupher M; Thannickal VJ; Wynn TA
Annu Rev Pathol; 2013 Jan; 8():241-76. PubMed ID: 23092186
[TBL] [Abstract][Full Text] [Related]
4. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis.
Chang FC; Chou YH; Chen YT; Lin SL
J Formos Med Assoc; 2012 Nov; 111(11):589-98. PubMed ID: 23217594
[TBL] [Abstract][Full Text] [Related]
5. Origin of myofibroblasts and cellular events triggering fibrosis.
Mack M; Yanagita M
Kidney Int; 2015 Feb; 87(2):297-307. PubMed ID: 25162398
[TBL] [Abstract][Full Text] [Related]
6. Healing scars: targeting pericytes to treat fibrosis.
Greenhalgh SN; Conroy KP; Henderson NC
QJM; 2015 Jan; 108(1):3-7. PubMed ID: 24659747
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis.
Chen YT; Chang FC; Wu CF; Chou YH; Hsu HL; Chiang WC; Shen J; Chen YM; Wu KD; Tsai TJ; Duffield JS; Lin SL
Kidney Int; 2011 Dec; 80(11):1170-81. PubMed ID: 21716259
[TBL] [Abstract][Full Text] [Related]
8. Mechanical aspects of lung fibrosis: a spotlight on the myofibroblast.
Hinz B
Proc Am Thorac Soc; 2012 Jul; 9(3):137-47. PubMed ID: 22802288
[TBL] [Abstract][Full Text] [Related]
9. LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1.
Ren S; Johnson BG; Kida Y; Ip C; Davidson KC; Lin SL; Kobayashi A; Lang RA; Hadjantonakis AK; Moon RT; Duffield JS
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1440-5. PubMed ID: 23302695
[TBL] [Abstract][Full Text] [Related]
10. Perivascular Cells in Diffuse Cutaneous Systemic Sclerosis Overexpress Activated ADAM12 and Are Involved in Myofibroblast Transdifferentiation and Development of Fibrosis.
Cipriani P; Di Benedetto P; Ruscitti P; Liakouli V; Berardicurti O; Carubbi F; Ciccia F; Guggino G; Zazzeroni F; Alesse E; Triolo G; Giacomelli R
J Rheumatol; 2016 Jul; 43(7):1340-9. PubMed ID: 27252423
[TBL] [Abstract][Full Text] [Related]
11. Bone Marrow-Derived Mesenchymal Stem Cells Transplantation Attenuates Renal Fibrosis Following Acute Kidney Injury in Rats by Diminishing Pericyte-Myofibroblast Transition and Extracellular Matrix Augment.
Wang H; Li M; Fei L; Xie C; Ding L; Zhu C; Zeng F; Liu N
Transplant Proc; 2023; 55(1):225-234. PubMed ID: 36604251
[TBL] [Abstract][Full Text] [Related]
12. Activation of pericytes: recent insights into kidney fibrosis and microvascular rarefaction.
Fligny C; Duffield JS
Curr Opin Rheumatol; 2013 Jan; 25(1):78-86. PubMed ID: 23196325
[TBL] [Abstract][Full Text] [Related]
13. Regulation of fibrotic changes by the synergistic effects of cytokines, dimensionality and matrix: Towards the development of an in vitro human dermal hypertrophic scar model.
Chawla S; Ghosh S
Acta Biomater; 2018 Mar; 69():131-145. PubMed ID: 29330036
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Matrix Stiffness Regulates Microvascular Stability by Controlling Endothelial Paracrine Signaling to Determine Pericyte Fate.
Yu Y; Leng Y; Song X; Mu J; Ma L; Yin L; Zheng Y; Lu Y; Li Y; Qiu X; Zhu H; Li J; Wang D
Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):1887-1899. PubMed ID: 37650330
[TBL] [Abstract][Full Text] [Related]
15. TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases.
Pardali E; Sanchez-Duffhues G; Gomez-Puerto MC; Ten Dijke P
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039786
[TBL] [Abstract][Full Text] [Related]
16. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis.
Iwaisako K; Brenner DA; Kisseleva T
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):65-8. PubMed ID: 22320919
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human PDGFR-β-positive pericytes from IPF and non-IPF lungs.
Wilson CL; Stephenson SE; Higuero JP; Feghali-Bostwick C; Hung CF; Schnapp LM
Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L991-L1002. PubMed ID: 30335500
[TBL] [Abstract][Full Text] [Related]
18. Decoding myofibroblast origins in human kidney fibrosis.
Kuppe C; Ibrahim MM; Kranz J; Zhang X; Ziegler S; Perales-Patón J; Jansen J; Reimer KC; Smith JR; Dobie R; Wilson-Kanamori JR; Halder M; Xu Y; Kabgani N; Kaesler N; Klaus M; Gernhold L; Puelles VG; Huber TB; Boor P; Menzel S; Hoogenboezem RM; Bindels EMJ; Steffens J; Floege J; Schneider RK; Saez-Rodriguez J; Henderson NC; Kramann R
Nature; 2021 Jan; 589(7841):281-286. PubMed ID: 33176333
[TBL] [Abstract][Full Text] [Related]
19. Targeting pericyte differentiation as a strategy to modulate kidney fibrosis in diabetic nephropathy.
Humphreys BD
Semin Nephrol; 2012 Sep; 32(5):463-70. PubMed ID: 23062987
[TBL] [Abstract][Full Text] [Related]
20. Notch1 promotes the pericyte-myofibroblast transition in idiopathic pulmonary fibrosis through the PDGFR/ROCK1 signal pathway.
Wang YC; Chen Q; Luo JM; Nie J; Meng QH; Shuai W; Xie H; Xia JM; Wang H
Exp Mol Med; 2019 Mar; 51(3):1-11. PubMed ID: 30902967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
